Paul G. Ince

39.8k citations

295 papers · 21.7k indexed · 3 hit papers · h-index 80

Neurology top 0.02%
Physiology top 0.1%
Molecular Biology top 1%
Neurology top 0.05%
Cellular and Molecular Neuroscience top 0.2%

Co-authors: Pamela J. Shaw Stephen B. Wharton Carol Brayne Fiona E. Matthews Ian G. McKeith John T. O’Brien Julie E. Simpson George M. Savva
Topics: Alzheimer's disease research and treatments (84 papers)Amyotrophic Lateral Sclerosis Research (69 papers)Parkinson's Disease Mechanisms and Treatments (52 papers)
Cited by: Neurology Genetics
Journals: New England Journal of Medicine The Lancet Nature Genetics
Partner nations: United Kingdom United States Australia

In The Last Decade

Paul G. Ince

292 papers receiving 21.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations

2007 761 citations Paul G. Ince, J. Robin Highley et al. profile →
Age, Neuropathology, and Dementia

2009 669 citations Stephen B. Wharton, Paul G. Ince et al. profile →
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria

2017 590 citations Michael J. Strong, Sharon Abrahams et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration profile →

Peers

Countries citing papers authored by Paul G. Ince

Since Specialization

Citations

This map shows the geographic impact of Paul G. Ince's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul G. Ince with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul G. Ince more than expected).

Fields of papers citing papers by Paul G. Ince

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul G. Ince. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul G. Ince. The network helps show where Paul G. Ince may publish in the future.

Co-authorship network of co-authors of Paul G. Ince

This figure shows the co-authorship network connecting the top 25 collaborators of Paul G. Ince. A scholar is included among the top collaborators of Paul G. Ince based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul G. Ince. Paul G. Ince is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insights into the pathological basis of dementia from population‐based neuropathology studies 2023 ·Neuropathology and Applied Neurobiology ·Stephen B. Wharton,Julie E. Simpson,Paul G. Ince,Connor D. Richardson,Richard L. Merrick,Fiona E. Matthews,Carol Brayne,(unknown)	10
2	Type 2 diabetes mellitus-associated transcriptome alterations in cortical neurones and associated neurovascular unit cells in the ageing brain 2021 ·Acta Neuropathologica Communications ·(unknown),Joanna J. Bury,(unknown),Paul R. Heath,Paul G. Ince,Pamela J. Shaw,Fiona E. Matthews,Carol Brayne,Julie E. Simpson,Stephen B. Wharton	32
3	Tissue microarray (TMA) use in post mortem neuropathology 2020 ·Journal of Neuroscience Methods ·L Wilson,(unknown),(unknown),Santiago Coelho,Alejandro F. Frangi,José M. Pozo,Paul G. Ince,J. Robin Highley	5
4	Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain Cohort 2020 ·Journal of Neuropathology & Experimental Neurology ·(unknown),Joanna J. Bury,Thaı́s Minett,Connor D. Richardson,Carol Brayne,Paul G. Ince,Pamela J. Shaw,Claire J. Garwood,Paul R. Heath,Julie E. Simpson,Fiona E. Matthews,Stephen B. Wharton	11
5	Expression of p16 and p21 in the frontal association cortex of ALS/MND brains suggests neuronal cell cycle dysregulation and astrocyte senescence in early stages of the disease 2019 ·Neuropathology and Applied Neurobiology ·(unknown),Claire J. Garwood,Paul R. Heath,Julie E. Simpson,Paul G. Ince,Stephen B. Wharton	63
6	Combined fused in sarcoma‐positive (FUS+) basophilic inclusion body disease and atypical tauopathy presenting with an amyotrophic lateral sclerosis/motor neurone disease (ALS/MND)‐plus phenotype 2019 ·Neuropathology and Applied Neurobiology ·Stephen B. Wharton,Nick Verber,Bart Wagner,J. Robin Highley,(unknown),Rachel Waller,Kate Strand,Paul G. Ince,Pamela J. Shaw	6
7	Quantitative histomorphometry of capillary microstructure in deep white matter 2019 ·NeuroImage Clinical ·(unknown),José M. Pozo,Santiago Coelho,(unknown),Julie E. Simpson,J. Robin Highley,Paul G. Ince,Alejandro F. Frangi	7
8	Proteomic and cellular localisation studies suggest non‐tight junction cytoplasmic and nuclear roles for occludin in astrocytes 2018 ·European Journal of Neuroscience ·(unknown),Claire J. Garwood,(unknown),Julie E. Simpson,Lydia M. Castelli,Paul R. Heath,(unknown),(unknown),(unknown),Paul G. Ince,Mark J. Dickman,Guillaume M. Hautbergue,Stephen B. Wharton	13
9	TREM2 expression in the human brain: a marker of monocyte recruitment? 2017 ·Brain Pathology ·(unknown),Sonja Rakić,J.D. Classey,Carol Brayne,Paul G. Ince,James A. R. Nicoll,Delphine Boche,(unknown)	53
10	Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteriabreakdown → 2017 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Michael J. Strong,Sharon Abrahams,Laura H. Goldstein,Susan Woolley,Paula McLaughlin,Julie S. Snowden,Eneida Mioshi,Angela Roberts,Michael Benatar,Tibor Hortobágyi,Jeffrey Rosenfeld,Vincenzo Silani,Paul G. Ince,Martin R. Turner	590
11	Neurodegeneration caused by intronic expansions of C9ORF72 is a clinically heterogeneous but pathologically distinct disease 2013 ·The Lancet ·Johnathan Cooper‐Knock,J. Robin Highley,Judith Hartley,Antonio Milano,Stephen Sawcer,(unknown),(unknown),Gavin Charlesworth,Nicholas Wood,Oliver Bandmann,Christopher McDermott,Janine Kirby,Paul G. Ince,Pamela J. Shaw	1
12	Sensory neuronopathy in patients harbouring recessive polymerase γ mutations 2011 ·Brain ·Nichola Z. Lax,Roger G. Whittaker,Philippa D. Hepplewhite,Amy K. Reeve,Emma L. Blakely,Evelyn Jaros,Paul G. Ince,Robert W. Taylor,P. Fawcett,Douglass M. Turnbull	51
13	TAR-DNA binding protein-43 and alterations in the hippocampus 2010 ·Brain Pathology ·Tuomas Rauramaa,Maria Pikkarainen,Elisabet Englund,Paul G. Ince,K. A. Jellinger,Anders Paetau,Irina Alafuzoff	1
14	Reactive Oxygen Species Regulate Neutrophil Recruitment and Survival in Pneumococcal Pneumonia 2008 ·American Journal of Respiratory and Critical Care Medicine ·Helen M. Marriott,L. Elizabeth Jackson,Thomas S. Wilkinson,A. John Simpson,Timothy J. Mitchell,David J. Buttle,Simon S. Cross,Paul G. Ince,Paul G. Hellewell,Moira K. B. Whyte,David H. Dockrell	63
15	White matter lesions in an unselected cohort of the elderly: Prevalence, relation to other patholgies and risk factors 2006 ·Brain Pathology ·Paul G. Ince,Malee Fernando,Fiona E. Matthews,Carol Brayne,James Lowe,M M Esiri,John T. O’Brien	1
16	Decreased Alveolar Macrophage Apoptosis Is Associated with Increased Pulmonary Inflammation in a Murine Model of Pneumococcal Pneumonia 2006 ·The Journal of Immunology ·Helen M. Marriott,Paul G. Hellewell,Simon S. Cross,Paul G. Ince,Moira K. B. Whyte,David H. Dockrell	75
17	White Matter Lesions in an Unselected Cohort of the Elderly 2006 ·Stroke ·Malee Fernando,Julie E. Simpson,Fiona E. Matthews,Carol Brayne,Claire E. Lewis,Robert Barber,Raj N. Kalaria,Gill Forster,Filomena Esteves,Stephen B. Wharton,Pamela J. Shaw,John T. O’Brien,Paul G. Ince	463
18	Alveolar Macrophage Apoptosis Contributes to Pneumococcal Clearance in a Resolving Model of Pulmonary Infection 2003 ·The Journal of Immunology ·David H. Dockrell,Helen M. Marriott,Lynne R. Prince,Victoria Ridger,Paul G. Ince,Paul G. Hellewell,Moira K. B. Whyte	177
19	Dementia with Lewy Bodies 2001 ·Advances in experimental medicine and biology ·Paul G. Ince	13
20	Neuropathology of a community sample of elderly demented and non-demented people 2000 ·Brain Pathology ·Paul G. Ince,John H. Xuereb,J. M. MacKenzie,(unknown),James Lowe,(unknown),Fiona E. Matthews,Carol Brayne,M M Esiri	4

About Paul G. Ince

Paul G. Ince is a scholar working on Neurology, Neurology and Psychiatry and Mental health, having authored 295 papers that have together received 21.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (84 papers), Amyotrophic Lateral Sclerosis Research (69 papers) and Parkinson's Disease Mechanisms and Treatments (52 papers). The work is most often cited by research in Neurology (5.1k citations), Neurology (9.2k citations) and Genetics (3.1k citations). Paul G. Ince has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Pamela J. Shaw, Stephen B. Wharton, Carol Brayne, Fiona E. Matthews, Ian G. McKeith, John T. O’Brien, Julie E. Simpson, George M. Savva, Clive Ballard and Janet Y. Slade. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact